时间：2020-07-22 08:16:40人气：8666来源： 迪拜新闻网
File photo shows a staff member displays samples of the COVID-19 inactivated vaccine at Sinovac Biotech Ltd., in Beijing. (Xinhua File/Zhang Yuwei)
A phase 2 trial of a COVID-19 vaccine candidate in China has found that the vaccine is safe and induces an immune response, according to a new study published Monday in medical journal The Lancet.
First satellite made in Xiongan enters orbit
(6000)人喜欢2026-08-20
Football tournament players experience martial arts in Guangdong
(6010)人喜欢2026-08-16
Free village swimming pool becomes summer hotspot for children in east China
(6018)人喜欢2026-08-12
Alternative water sources make up over 45% of Hangzhou's sanitation use
(4017)人喜欢2026-08-08
Chinese scenic spots taps night tours to boost summer consumption
(5847)人喜欢2026-08-04
China-Laos Railway cargo volume exceeds 86 million metric tons
(4425)人喜欢2026-07-30
Global youth camp concludes in Shanghai
(6048)人喜欢2026-07-24
Yangtze River Delta launches first China-Kyrgyzstan-Uzbekistan multimodal freight train
(4452)人喜欢2026-07-19